Sort
11,323 grants matching “glioblastoma”
Defining cellular states of quiescence in human brain tumors
$183,754Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2022 · NS
AP 4. Drug Screening and Pharmacology
$183,600Eric W Schmidt · University Of Utah · U19 · FY2017 · TW
AP 4. Drug Screening and Pharmacology
$183,600Eric W Schmidt · University Of Utah · U19 · FY2018 · TW
Neurologic Oncology Program
$183,261Susan M Chang · University Of California, San Francisco · P30 · FY2024 · CA
Neurologic Oncology Program
$183,249Susan M Chang · University Of California, San Francisco · P30 · FY2023 · CA
Research Training Program in Neuro-Oncology
$183,235Brian Patrick O'Neill · Mayo Clinic Rochester · T32 · FY2012 · NS
Donor Innate Lymphocyte Infusion Product for Immunotherapy of Glioblastoma Multif
$183,125Lawrence S Lamb · University Of Alabama At Birmingham · R21 · FY2010 · NS
Integrating Genomic Data and Biological Knowledge to Learn Context-Specific Gene
$183,012Seungchan Kim · Arizona State University-Tempe Campus · R21 · FY2008 · LM
Genes and pathways underlying brain overgrowth and focal cortical malformations
$182,962Ghayda Mirzaa · Seattle Children'S Hospital · K08 · FY2015 · NS
Genes and pathways underlying brain overgrowth and focal cortical malformations
$182,962Ghayda Mirzaa · Seattle Children'S Hospital · K08 · FY2016 · NS
Phase I Vaccine Study using Brain Tumor Initiating Cells in WHO Grade II Gliomas
$182,958Hideho Okada · University Of California, San Francisco · R21 · FY2014 · CA
Targeting cancer stem cells for brain tumor therapy
$182,813John S Yu · Cedars-Sinai Medical Center · R21 · FY2008 · CA
Administrative Core
$182,748Li Ding · Washington University · U2C · FY2023 · CA
BRAIN TUMOR BIOREPOSITORY, HISTOPATHOLOGY, AND IMMUNOLOGIC MONITORING
$182,736Roger E McLendon · Duke University · P50 · FY2012 · NS
PET Imaging Agents for Protoporphyrin IX
$182,568Mark Myron Goodman · Emory University · R21 · FY2021 · CA
Polymeric Micelles for Targeted Delivery of Contrast Agents Through the Nose-to-Brain Route in Image-Guided Brain Cancer Surgery
$182,500Hyunah Cho · St. John'S University · R16 · FY2024 · GM
North Carolina A&T University-Wake Forest Cancer Center partnership (1of 2)
$182,438Mary A Smith · North Carolina Agri & Tech St Univ · P20 · FY2008 · CA
Armed oncolytic parvoviral vectors for modulating the tumor microenvironment
$182,156Peter Tattersall · Yale University · R21 · FY2019 · CA
Identification of RhoGEFs as novel therapeutic targets for malignant glioma
$182,124Marc H Symons · Feinstein Institute For Medical Research · R21 · FY2008 · NS
Molecular mechanism of PID1, a novel tumor inhibitor, in glioblastomas
$182,109Anat Erdreich-Epstein · Children'S Hospital Of Los Angeles · R21 · FY2016 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2021 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2018 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2020 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2019 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2017 · NS